Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine

Schizophrenia Research

Volumn 56, Issue 1-2, 2002, Pages 11-17

  Markianos, M ^a   Hatzimanolis, J ^a   Lykouras, L ^a   Christodoulou, G N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clomipramine; Clozapine; Haloperidol; Olanzapine; Prolactin; Schizophrenia

Indexed keywords

CLOMIPRAMINE; CLOZAPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; OLANZAPINE; PROLACTIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RECEPTOR BLOCKING; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; CLOMIPRAMINE; CLOZAPINE; HALOPERIDOL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PIRENZEPINE; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0036642242     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00221-3     Document Type: Article

References (30)

1. Neuroendocrine responsivity to clomipramine challenge test in neuroleptic naïve psychotic patients before and after treatment with haloperidol
2. Radioreceptor binding profile of the atypical antipsychotic olanzapine
3. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects
4. The acute and long-term effect of olanzapine compared with placebo on serum prolactin levels
5. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement
6. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extrapyramidal side effects
7. The effects of intravenous clomipramine on neurohormones in normal subjects
8. Abnormal neuroendocrine responsivity to acute IV clomipramine challenge in depressed patients
9. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat
10. Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: Implications for the mechanism of action of clozapine
11. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
12. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
13. Neuroendocrine tests during treatment with neuroleptic drugs. I. Plasma prolactin response to haloperidol challenge
14. Comparison of growth hormone and prolactin stimulation induced by clomipramine and desipramine in man in connection with clomipramine metabolism
15. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia
16. Hormonal response to fenfluramine challenges in clozapine-treated schizophrenic patients
17. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients
18. Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients
19. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone
20. Effect of clozapine on human serum prolactin levels
21. Effects of haloperidol treatment on prolactin response to D-fenfluramine challenge in acute schizophrenia
22. Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals
23. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects - A double-blind PET study of schizophrenic patients
24. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients
25. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia
26. Prolactin and antipsychotic medications: Mechanism of action
27. Selective serotonin reuptake inhibitors and neuroendocrine function
28. In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine
29. Receptor pharmacology of neuroleptics: Relation to clinical effects
30. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol